Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.35% | 19.74% | 23.49% | 16.65% | 11.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.35% | 19.74% | 23.49% | 16.65% | 11.75% |
| Cost of Revenue | 7.02% | 5.51% | 3.72% | 0.43% | -3.36% |
| Gross Profit | 16.40% | 27.47% | 35.36% | 26.22% | 20.84% |
| SG&A Expenses | 8.02% | 12.79% | 22.49% | 16.52% | 12.12% |
| Depreciation & Amortization | -0.61% | -0.58% | 0.35% | -0.99% | 0.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.63% | 8.52% | 12.26% | 6.83% | 2.32% |
| Operating Income | 42.43% | 82.10% | 96.02% | 82.64% | 85.78% |
| Income Before Tax | 51.88% | 76.72% | 182.67% | 401.21% | 280.43% |
| Income Tax Expenses | 286.01% | 638.19% | 51.45% | 278.85% | 24.33% |
| Earnings from Continuing Operations | 31.59% | 50.13% | 216.18% | 422.28% | 363.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.59% | 50.13% | 216.18% | 422.28% | 363.08% |
| EBIT | 42.43% | 82.10% | 96.02% | 82.64% | 85.78% |
| EBITDA | 28.30% | 50.29% | 56.64% | 50.47% | 47.83% |
| EPS Basic | 32.21% | 51.10% | 219.13% | 425.13% | 364.81% |
| Normalized Basic EPS | 53.58% | 95.99% | 114.09% | 116.06% | 74.58% |
| EPS Diluted | 30.97% | 50.00% | 220.16% | 425.84% | 368.77% |
| Normalized Diluted EPS | 53.03% | 96.34% | 115.34% | 116.18% | 73.87% |
| Average Basic Shares Outstanding | -0.78% | -0.91% | -0.88% | -0.37% | -0.16% |
| Average Diluted Shares Outstanding | -0.58% | -1.17% | -1.42% | -0.34% | 0.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |